Yoshinori Hashimoto, Hiromi Omura, Takayuki Tanaka (Department of Hematology, Tottori Prefectural Central Hospital, Tottori, Japan)
Session information
Oral Session
Oral Session 3-12D MPN: Clinical
Sun. Oct 13, 2019 3:40 PM - 4:40 PM No.12 (Tokyo International Forum, 5F G510)
Chair: Kohshi Ohishi (Mie University Hospital, Dep. of Transfusion Medicine and Cell Therapy)
Makoto Murata1,11, Katsuto Takenaka2,11, Naoyuki Uchida3, Yukiyasu Ozawa4, Kazuteru Ohashi5, Sung-Won Kim6, Kazuhiro Ikegame7, Makoto Hirokawa8, Takahiro Fukuda6, Yoshiko Atsuta9, Takeshi Kondo10,11 (1.Hematology and Oncology, Nagoya University, Nagoya, Japan, 2.Hematology, Clinical Immunology and Infectious Diseases, Ehime University, Toon, Japan, 3.Hematology, Toranomon Hospital, Tokyo, Japan, 4.Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 5.Hematology, Komagome Hospital, Tokyo, Japan, 6.Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan, 7.Hematology, Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, 8.General Internal Medicine and Clinical Laboratory Medicine, Akita University, Akita, 9.Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan, 10.Hematology, Aiiku Hospital, Sapporo, Japan, 11.Adult CML/MPN Working Group, JSHCT, Japan)
Tadaaki Inano1, Marito Araki2, Soji Morishita2, Tomonori Ochiai1, Kyohei Misawa1, Yasutaka Fukuda1, Naoko Midorikawa1, Mai Nudejima1, Masafumi Ito3, Satoshi Osaga4, Yoko Edahiro1, Misa Imai1,5, Teppei Taguchi1, Maho Okuda1,6, Akimichi Ohsaka2, Norio Komatsu1 (1.Hematol, Juntendo Univ. Graduate School of Med., Tokyo, Japan, 2.Transfusion Med. & Stem Cell Regu., Juntendo Univ., 3.Pathol, Japanese Red Cross Nagoya Daiichi Hosp., Aichi, Japan, 4.Clinical Research Management Center, Nagoya City Univ. Hosp., Aichi, Japan, 5.Center for Development and Research of Cancer Med., Juntendo Univ., 6.Institute for Environmental and Gender Specific Med., Juntendo Univ.)
Yusuke Yamane, Miki Kiyota, Akio Onishi, Mio Sugitani, Katsuya Wada (Hematol., Matsushita Memorial Hospital, Moriguchi, Japan)
Miyuki Tsutsui1, Soji Morishita2, Takashi Nishino3, Yoko Edahiro1, Satoshi Tsuneda3, Marito Araki2, Akimichi Ohsaka2, Norio Komatsu1 (1.Department of Hematol., Juntendo Univ., Tokyo, Japan, 2.Dept. Transfus. Med. and Stem Cell Reg., Juntendo Univ., Japan, 3.Life Sci. and Med. Biosci., Waseda Univ., Tokyo, Japan)
Kazuhide Iizuka1,2,3, Noriyoshi Iriyama1, Soji Morishita3,5, Katsuhiro Miura1, Yoshikazu Iizuka1, Yuji Nishizaki4, Naotake Yanagisawa4, Jun Ando3, Yoshihito Uchino1, Hiromichi Takahashi1,2, Masaru Nakagawa1, Takashi Hamada1, Yoshihiro Hatta1, Tomohiro Nakayama2, Masami Takei1, Norio Komatsu3 (1.Hematology and Rheumatology, Nihon Univ., Tokyo, Japan, 2.Laboratory Medicine, Nihon Univ., Tokyo, Japan, 3.Hematology, Juntendo Univ., Tokyo, Japan, 4.Medical Technology Innovation Center, Juntendo Univ., Tokyo, Japan, 5.Transfusion Medicine and Stem Cell Regulation, Juntendo Univ, Tokyo, Japan)